| Dr John Stephen Thurber, MD | |
|
3056 Healthy Way Ste 100, Birmingham, AL 35243-2435 | |
| (205) 930-2925 | |
| Not Available |
| Full Name | Dr John Stephen Thurber |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 30 Years |
| Location | 3056 Healthy Way Ste 100, Birmingham, Alabama |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699737155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 24029 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's East | Birmingham, AL | Hospital |
| St Vincent's Birmingham | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stv Cardiothoracic Surgeons Llc | 7618262155 | 12 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
| Entity Name | Baptist Health Center - Princeton Cardiothoracic Surgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326388158 PECOS PAC ID: 4880849272 Enrollment ID: O20130311000339 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
| Entity Name | Stv Cardiothoracic Surgeons Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649624255 PECOS PAC ID: 7618262155 Enrollment ID: O20160823002996 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
| Entity Name | Baptist Health Centers Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265496236 PECOS PAC ID: 3476457011 Enrollment ID: O20180124001442 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Stephen Thurber, MD 3056 Healthy Way Ste 100, Birmingham, AL 35243-2435 Ph: (205) 930-2925 | Dr John Stephen Thurber, MD 3056 Healthy Way Ste 100, Birmingham, AL 35243-2435 Ph: (205) 930-2925 |
News Archive
Researchers at the University of Alabama at Birmingham have launched the first drug study aimed at preventing or delaying the onset of epilepsy in children with a genetic condition known as tuberous sclerosis complex.
In the United States, suicide is twice as common as homicide - and more often involves firearms - but public perception is just the opposite.
Clavis Pharma ASA, the clinical stage oncology focused pharmaceutical company, and Clovis Oncology, Inc., the newly formed oncology company led by former Pharmion Corporation executives, announced today an agreement for the further development and commercialisation of the Clavis Pharma drug candidate, CP-4126, currently in Phase II development in pancreatic cancer.
Skatchewan is a vast prairie province in the middle of Canada. It's home to hockey great Gordie Howe and the world's first curling museum. But Canadians know it for another reason: it's the birthplace of the country's single-payer health-care system.
› Verified 8 days ago
Dr. Benjamin Wei, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Kyle Eudailey, Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Hurley W Knott, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 860 Montclair Rd, Birmingham, AL 35213 Phone: 205-599-3700 | |
Dr. John B Casterline, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2871 Acton Road, Suite 100, Birmingham, AL 35243 Phone: 205-939-0023 Fax: 205-939-4180 | |
Dr. Stanley K Lochridge, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2871 Acton Road, Suite 100, Birmingham, AL 35243 Phone: 205-939-0023 Fax: 205-939-4180 | |
Dr. John B Richardson Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: May Accept Medicare Assignments Practice Location: 2871 Acton Road, Suite 100, Birmingham, AL 35243 Phone: 205-939-0023 Fax: 205-939-4180 | |
Dr. Carlton Duane Randleman Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2704 20th St S, Ste 100, Birmingham, AL 35209 Phone: 205-592-1800 |